ReviewPublished 23 July 2026The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agentsAbeer Qasim · Rayan Alataa · Fnu Veena · Elona ShehiFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1850915
Systematic ReviewPublished 20 July 2026Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 studyShashank Joshi · Shambo Samrat Samajdar · Arvind Gupta · Mithun Bhartia · Sailesh Lodha · Supratik Bhattacharyya · Krishna Seshadri · Lakshmi Nagendra · A. G. Unnikrishnan · Dakshata Padhye · Lakshmi Nalini Kopalle · Ashok Kumar Das · Om Lakhani · Jothydev Kesavadev · Ameya Joshi · Sambit Das · Smriti Gadia · Thamburaj AnthuvanFrontiers in Clinical Diabetes and Healthcaredoi 10.3389/fcdhc.2026.1733995
ReviewPublished 31 March 2026Revisiting old drugs and drug combinations for polycythemia vera and related neoplasmsGökhan Mergen · Hans C. HasselbalchFrontiers in Hematologydoi 10.3389/frhem.2026.1749376
